![Matthew Henn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Henn
President at
SERES THERAPEUTICS, INC.
Net worth: 57 374 $ as of 2026-05-30
Profile
Matthew R.
Henn is currently Director at The Microbiome Therapeutics Innovation Group and President & Chief Scientific Officer at Seres Therapeutics, Inc. Former roles include Director at Viral Genomics, Inc. and Director-Viral Genomics at The Broad Institute, Inc. from 2005 to 2012.
Education includes a doctorate from the University of California, Berkeley and an undergraduate degree from the University of New Hampshire.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-17 | 7,838 ( 0.08% ) | 57 374 $ | 2026-05-30 |
Matthew Henn active positions
| Companies | Position | Start |
|---|---|---|
| SERES THERAPEUTICS, INC. | President | 2026-03-01 |
Former positions of Matthew Henn
| Companies | Position | End |
|---|---|---|
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology Engages in research and development in bio medicals to cure infectious disease, cancer, psychiatric research and cardiovascular diseases | Corporate Officer/Principal | 2012-05-31 |
Viral Genomics, Inc. | Director/Board Member | - |
Training of Matthew Henn
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
27
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of New Hampshire
 University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viral Genomics, Inc. | |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology Engages in research and development in bio medicals to cure infectious disease, cancer, psychiatric research and cardiovascular diseases | Health Technology |
Seres Therapeutics, Inc.
 Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
- Stock Market
- Insiders
- Matthew Henn
